NDC 51662-1581
Bupivacaine Hci 2.5 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from AuroMedics Pharma LLC's NDC 55150-249.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Eugia Pharma Specialities Limited | Sangareddy, India | Makes it, tests it and packages it | Serious problems, FDA actionFeb 6, 2026 · 7 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Apr 13, 2022 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupivacaine: every company that makes it
- Form
- injection, solution, infiltration; perineural
- Strength
- 2.5 mg per 1 mL
- Approval
- ANDA ANDA207183
- On the market since
- Jul 10, 2022
- Package NDCs
51662-1581-251662-1581-3- Official label
- DailyMed (National Library of Medicine), updated Jan 22, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?